Oesophageal Cancer Trial, Recruiting NCT06037902 Sponsor: Sheba Medical Center Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06037902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with cancer that has a tumour in the oesophagus (food pipe), including tumours at the point where the oesophagus meets the stomach
  • People who are 18 years of age or older
  • People who are planned to receive radiation therapy as part of their treatment
  • People whose general level of physical functioning scores at least 60 on a standard medical scale called the Karnofsky scale (confirm with trial site)
  • People whose life expectancy is at least two months
  • People who are able to read, understand, and sign a consent form of their own free will before any study procedures begin
  • People who are physically able to undergo treatment planning and radiation therapy while wearing a CPAP device (a mask that delivers steady airflow, often used for sleep apnoea)
  • People whose radiation treatment is planned as a main treatment, a palliative treatment (to manage symptoms), or pre-surgery treatment — with or without chemotherapy

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People who have a serious existing health condition that would prevent the safe use of a CPAP device
  • People who are currently living in an institution under an administrative or court order
  • People who belong to a defined "special population" (confirm with trial site for clarification)
  • People who have a history of a psychiatric condition that may affect their ability to understand the study requirements, participate fully, or give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 August 2023
Est. completion
30 September 2027

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

absolute mean heart radiation dose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov